Clinical Trial Update: Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating doxycycline as preventive treatment in individuals at risk for fatal familial insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatal Familial Insomnia

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Familial Fatal Insomnia | Phase 2 | Status: COMPLETED